Ovarian/Breast Cancer (Genetics)

Educational Seminar Sponsored on BRACAnalysis Testing

Published in Cancer Weekly, November 25th, 1996

"The Role of the Oncology Nurse in Breast and Ovarian Cancer Genetic Susceptibility Testing" was the topic of discussion at a seminar during the Fall Institute of the Oncology Nursing Society, held in Phoenix, Arizona.

The seminar was sponsored through an educational grant from Myriad Genetic Laboratories, Inc., which offers BRACAnalysis - comprehensive BRCA1 and BRCA2 sequence analysis for susceptibility to breast and ovarian cancers. BRCA1 and BRCA2 gene mutations are responsible for about 90 percent of all hereditary ovarian and early-onset breast cancers.

Jean Jenkins, R.N., M.S.N., National Center for Human Genome Research, summed up the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1996-11-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry